Sarah Meshberg-Cohen, PhD

Sarah Meshberg-Cohen, Ph.D., is a clinical psychologist with a background in behavioral medicine, and specializes in the treatment of substance use disorders, chronic depression, anxiety, posttraumatic stress disorder (PTSD), and dual diagnosis. Dr. Meshberg-Cohen serves as the Director of the VACHS Outpatient Addiction Recovery Service and Program Manager of VACHS Addiction Firm. Her clinical work utilizes evidence-based treatments, including cognitive behavioral therapy, motivational enhancement, cognitive processing therapy, written exposure therapy, and cognitive behavioral analysis system of psychotherapy (CBASP). Her research focuses on improving evidence-based treatments for substance use disorders and comorbid psychiatric conditions, often involving trauma. She is the Principal Investigator on a grant-funded randomized clinical trial investigating the feasibility and efficacy of written exposure therapy (WET) for veterans seeking SUD treatment who present with comorbid PTSD. Dr. Meshberg-Cohen also serves as co-Investigator on a clinical trial examining the impact of cognitive processing therapy with buprenorphine maintenance for veterans with comorbid opioid use disorder and PTSD.